GINA ZEIDMAN: Open Payments
NPI 1518337708 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 19 payments from 7 companies in 2025. Trend: 2023 $173 · 2024 $238 · 2025 $332
Food & beverage: $197Education: $135
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 6 | $176 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $51 |
| Exeltis, USA Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Organon LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Evofem Biosciences, Inc. | 2 | $10 |
Products named: SLYND, INTRAROSA, Kyleena, NEXPLANON, Dexcom G6 Transmitter, FEMRING, Phexxi.
Industry payments across GA — which companies pay providers there.
